.
I am relatively new to DMPI caught my attention early fall '15 and went straight to my watch list but I failed to act on it (was busy with my real job during the start of the Oct ascent) and I watched it get away on me lol when the pps was visiting the $1.50 area in Nov .. I was pretty mad at myself so needless to say the pull to these levels was an opportunity I was not letting slip twice....have bought in 3 tranches so far .85, .95 & 1.05 the highest cost being my starter in December.(I was fooled on the gap up day but didn't want to let it get away again lol)
Am absolutely willing to average up or down whichever way the wind blows .. pps seems to be shoring up in this range my long standing GTC @ .75 has never filled
We should see those warrants execute Q2 or 3 imo with the awareness here rapidly growing and the late breaking will bring more long term investors in short order. Share structure & low float is ideal for an organic up list one day and being QX adds to that credibility
I too was initially attracted to Delmar for the likelihood of a very rapid commercialization process having picked up successful but abandoned protocol and sales already underway in China, which lends further credence to the possibility of your speculation. Thanks for sharing, should be an exciting year!
Recent KTRA News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/30/2024 09:20:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/25/2024 09:27:10 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/25/2024 09:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 09:00:09 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/24/2024 12:35:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 12:30:08 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/20/2024 08:20:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:15:07 PM
- Kintara Therapeutics Announces Adjournment of Special Meeting of Stockholders until October 4, 2024 • PR Newswire (US) • 09/20/2024 01:25:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/18/2024 12:40:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 12:35:07 PM
- Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences • PR Newswire (US) • 09/18/2024 12:30:00 PM
- Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences • PR Newswire (US) • 09/18/2024 12:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/11/2024 12:40:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 12:35:09 PM
- Kintara Therapeutics Provides Update on Corporate Developments and REM-001 Clinical Study • PR Newswire (US) • 09/11/2024 12:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/09/2024 08:10:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:05:10 PM
- Kintara Therapeutics to Hold Special Meeting of Stockholders to Allow for Completion of the Proposed Merger with TuHURA Biosciences, Inc. • PR Newswire (US) • 09/09/2024 12:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/03/2024 09:25:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 09:20:24 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/19/2024 01:10:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 01:05:08 PM
- TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer • PR Newswire (US) • 08/19/2024 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/14/2024 04:15:13 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM